Eurofins Scientific SE
Eurofins Scientific SE ERFSF Peers
See (ERFSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ERFSF | $67.36 | +0.01% | 11.9B | 28.30 | $2.38 | +1.60% |
| LZAGY | $69.60 | +2.08% | 50.2B | 63.85 | $1.09 | +0.75% |
| LZAGF | $705.26 | +2.90% | 49.6B | 65.97 | $10.69 | +0.42% |
| WUXAY | $8.73 | -1.58% | 25B | 16.17 | $0.54 | +0.70% |
| WUXIF | $7.34 | N/A | 20.7B | 13.59 | $0.54 | +2.53% |
| BMXMF | $136.00 | +1.30% | 16B | 32.93 | $4.13 | +0.68% |
| SKHCF | $18.08 | +10.31% | 8.7B | 24.77 | $0.73 | +4.28% |
| SKHHY | $17.28 | -0.46% | 8.3B | 23.67 | $0.73 | +3.90% |
| DSRLF | $104.69 | N/A | 5.6B | 26.57 | $3.94 | +1.31% |
| HNGZY | $4.00 | N/A | 5.1B | 26.67 | $0.15 | +1.99% |
Stock Comparison
ERFSF vs LZAGY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, LZAGY has a market cap of 50.2B. Regarding current trading prices, ERFSF is priced at $67.36, while LZAGY trades at $69.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas LZAGY's P/E ratio is 63.85. In terms of profitability, ERFSF's ROE is +0.07%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs LZAGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, LZAGF has a market cap of 49.6B. Regarding current trading prices, ERFSF is priced at $67.36, while LZAGF trades at $705.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas LZAGF's P/E ratio is 65.97. In terms of profitability, ERFSF's ROE is +0.07%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs WUXAY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, WUXAY has a market cap of 25B. Regarding current trading prices, ERFSF is priced at $67.36, while WUXAY trades at $8.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas WUXAY's P/E ratio is 16.17. In terms of profitability, ERFSF's ROE is +0.07%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, ERFSF is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs WUXIF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, WUXIF has a market cap of 20.7B. Regarding current trading prices, ERFSF is priced at $67.36, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, ERFSF's ROE is +0.07%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, ERFSF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BMXMF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, BMXMF has a market cap of 16B. Regarding current trading prices, ERFSF is priced at $67.36, while BMXMF trades at $136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas BMXMF's P/E ratio is 32.93. In terms of profitability, ERFSF's ROE is +0.07%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, ERFSF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SKHCF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SKHCF has a market cap of 8.7B. Regarding current trading prices, ERFSF is priced at $67.36, while SKHCF trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SKHCF's P/E ratio is 24.77. In terms of profitability, ERFSF's ROE is +0.07%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, ERFSF is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SKHHY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SKHHY has a market cap of 8.3B. Regarding current trading prices, ERFSF is priced at $67.36, while SKHHY trades at $17.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SKHHY's P/E ratio is 23.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, ERFSF is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DSRLF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, DSRLF has a market cap of 5.6B. Regarding current trading prices, ERFSF is priced at $67.36, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas DSRLF's P/E ratio is 26.57. In terms of profitability, ERFSF's ROE is +0.07%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, ERFSF is more volatile compared to DSRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HNGZY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, HNGZY has a market cap of 5.1B. Regarding current trading prices, ERFSF is priced at $67.36, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, ERFSF is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VIMGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, ERFSF is priced at $67.36, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, ERFSF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MRCHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, ERFSF is priced at $67.36, while MRCHF trades at $21.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas MRCHF's P/E ratio is 61.83. In terms of profitability, ERFSF's ROE is +0.07%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, ERFSF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDGXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, ERFSF is priced at $67.36, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, ERFSF is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EDTXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, EDTXF has a market cap of 172.6M. Regarding current trading prices, ERFSF is priced at $67.36, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas EDTXF's P/E ratio is -10.09. In terms of profitability, ERFSF's ROE is +0.07%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, ERFSF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AMCY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, ERFSF is priced at $67.36, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas AMCY's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to AMCY's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NNGRF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, ERFSF is priced at $67.36, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, ERFSF's ROE is +0.07%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, ERFSF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CORBF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, CORBF has a market cap of 158.7M. Regarding current trading prices, ERFSF is priced at $67.36, while CORBF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas CORBF's P/E ratio is 3.59. In terms of profitability, ERFSF's ROE is +0.07%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, ERFSF is less volatile compared to CORBF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs THOXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, ERFSF is priced at $67.36, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas THOXF's P/E ratio is -14.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, ERFSF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DIUXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, ERFSF is priced at $67.36, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, ERFSF's ROE is +0.07%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, ERFSF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ANPCF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, ERFSF is priced at $67.36, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, ERFSF's ROE is +0.07%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, ERFSF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TIHE Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, ERFSF is priced at $67.36, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas TIHE's P/E ratio is 0.32. In terms of profitability, ERFSF's ROE is +0.07%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, ERFSF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, ERFSF is priced at $67.36, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, ERFSF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PCNEF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, ERFSF is priced at $67.36, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, ERFSF's ROE is +0.07%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, ERFSF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PFGTF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, ERFSF is priced at $67.36, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, ERFSF's ROE is +0.07%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, ERFSF is more volatile compared to PFGTF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CLIFF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, ERFSF is priced at $67.36, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, ERFSF's ROE is +0.07%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, ERFSF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, BIOQ has a market cap of 39.6M. Regarding current trading prices, ERFSF is priced at $67.36, while BIOQ trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas BIOQ's P/E ratio is 15.58. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, ERFSF is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ANPCY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ANPCY has a market cap of 31.2M. Regarding current trading prices, ERFSF is priced at $67.36, while ANPCY trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ANPCY's P/E ratio is -1.49. In terms of profitability, ERFSF's ROE is +0.07%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, ERFSF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SNANF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SNANF has a market cap of 30.3M. Regarding current trading prices, ERFSF is priced at $67.36, while SNANF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SNANF's P/E ratio is -14.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, ERFSF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IMMVF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, ERFSF is priced at $67.36, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, ERFSF's ROE is +0.07%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, ERFSF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PCHM Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, PCHM has a market cap of 21.9M. Regarding current trading prices, ERFSF is priced at $67.36, while PCHM trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas PCHM's P/E ratio is -0.02. In terms of profitability, ERFSF's ROE is +0.07%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, ERFSF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BMKDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, BMKDF has a market cap of 21.1M. Regarding current trading prices, ERFSF is priced at $67.36, while BMKDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas BMKDF's P/E ratio is -23.17. In terms of profitability, ERFSF's ROE is +0.07%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, ERFSF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VILGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, ERFSF is priced at $67.36, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas VILGF's P/E ratio is -0.30. In terms of profitability, ERFSF's ROE is +0.07%, compared to VILGF's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs LDXHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, LDXHF has a market cap of 19.5M. Regarding current trading prices, ERFSF is priced at $67.36, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas LDXHF's P/E ratio is -2.60. In terms of profitability, ERFSF's ROE is +0.07%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, ERFSF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PMSNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, ERFSF is priced at $67.36, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, ERFSF's ROE is +0.07%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, ERFSF is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ABDXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, ERFSF is priced at $67.36, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, ERFSF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IZOZF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IZOZF has a market cap of 11.6M. Regarding current trading prices, ERFSF is priced at $67.36, while IZOZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IZOZF's P/E ratio is -6.39. In terms of profitability, ERFSF's ROE is +0.07%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, ERFSF is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MXDHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, ERFSF is priced at $67.36, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, ERFSF's ROE is +0.07%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, ERFSF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VRCDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, ERFSF is priced at $67.36, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, ERFSF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SQIDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, ERFSF is priced at $67.36, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, ERFSF's ROE is +0.07%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, ERFSF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TDSGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, TDSGF has a market cap of 5.7M. Regarding current trading prices, ERFSF is priced at $67.36, while TDSGF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas TDSGF's P/E ratio is -1.90. In terms of profitability, ERFSF's ROE is +0.07%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, ERFSF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SLDX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SLDX has a market cap of 4.8M. Regarding current trading prices, ERFSF is priced at $67.36, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SLDX's P/E ratio is -0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, ERFSF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RNVA Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, ERFSF is priced at $67.36, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas RNVA's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, ERFSF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AVCRF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, AVCRF has a market cap of 4.3M. Regarding current trading prices, ERFSF is priced at $67.36, while AVCRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas AVCRF's P/E ratio is -4.23. In terms of profitability, ERFSF's ROE is +0.07%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, ERFSF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs JMPHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, ERFSF is priced at $67.36, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, ERFSF's ROE is +0.07%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, ERFSF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ICBU Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ICBU has a market cap of 3.7M. Regarding current trading prices, ERFSF is priced at $67.36, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ICBU's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, ERFSF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs GNTLF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, ERFSF is priced at $67.36, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, ERFSF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SZLSF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SZLSF has a market cap of 3.6M. Regarding current trading prices, ERFSF is priced at $67.36, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, ERFSF's ROE is +0.07%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, ERFSF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDXG Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IDXG has a market cap of 3.5M. Regarding current trading prices, ERFSF is priced at $67.36, while IDXG trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IDXG's P/E ratio is 2.79. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, ERFSF is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDTA Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IDTA has a market cap of 1.7M. Regarding current trading prices, ERFSF is priced at $67.36, while IDTA trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IDTA's P/E ratio is 4.15. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, ERFSF is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IBXXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, ERFSF is priced at $67.36, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, ERFSF's ROE is +0.07%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, ERFSF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IVRO Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IVRO has a market cap of 1.6M. Regarding current trading prices, ERFSF is priced at $67.36, while IVRO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IVRO's P/E ratio is -0.77. In terms of profitability, ERFSF's ROE is +0.07%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, ERFSF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NSTM Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, ERFSF is priced at $67.36, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas NSTM's P/E ratio is -0.44. In terms of profitability, ERFSF's ROE is +0.07%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, ERFSF is more volatile compared to NSTM. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DIGP Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, ERFSF is priced at $67.36, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas DIGP's P/E ratio is -1.04. In terms of profitability, ERFSF's ROE is +0.07%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, ERFSF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SCRSF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, SCRSF has a market cap of 906.3K. Regarding current trading prices, ERFSF is priced at $67.36, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, ERFSF's ROE is +0.07%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, ERFSF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RSHN Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, ERFSF is priced at $67.36, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas RSHN's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, ERFSF is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EPGNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, ERFSF is priced at $67.36, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, ERFSF's ROE is +0.07%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, ERFSF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MBGNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, ERFSF is priced at $67.36, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, ERFSF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NVTAQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, ERFSF is priced at $67.36, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ARYC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, ERFSF is priced at $67.36, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ARYC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, ERFSF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HCLC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, ERFSF is priced at $67.36, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas HCLC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, ERFSF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MEDVF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, ERFSF is priced at $67.36, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, ERFSF's ROE is +0.07%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, ERFSF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CHHL Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, ERFSF is priced at $67.36, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas CHHL's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IHTI Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, ERFSF is priced at $67.36, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas IHTI's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MEDD Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, ERFSF is priced at $67.36, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas MEDD's P/E ratio is -0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, ERFSF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TOMDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, ERFSF is priced at $67.36, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas TOMDF's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, ERFSF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ABMC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, ERFSF is priced at $67.36, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ABMC's P/E ratio is 0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, ERFSF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RGDXQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, ERFSF is priced at $67.36, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, ERFSF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs GWHP Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, ERFSF is priced at $67.36, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas GWHP's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CGNH Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, CGNH has a market cap of 1.2K. Regarding current trading prices, ERFSF is priced at $67.36, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas CGNH's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, ERFSF is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CYPS Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, CYPS has a market cap of 811. Regarding current trading prices, ERFSF is priced at $67.36, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas CYPS's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CYPS's ROE of N/A. Regarding short-term risk, ERFSF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ROSGQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, ERFSF is priced at $67.36, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, ERFSF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOCQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, ERFSF is priced at $67.36, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, ERFSF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HTGMQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, ERFSF is priced at $67.36, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, ERFSF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DMTKQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, DMTKQ has a market cap of 35. Regarding current trading prices, ERFSF is priced at $67.36, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, ERFSF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs OPGX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, OPGX has a market cap of 17. Regarding current trading prices, ERFSF is priced at $67.36, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas OPGX's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, ERFSF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BGNX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, BGNX has a market cap of 0. Regarding current trading prices, ERFSF is priced at $67.36, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas BGNX's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to BGNX's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AGHC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, AGHC has a market cap of 0. Regarding current trading prices, ERFSF is priced at $67.36, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas AGHC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, ERFSF is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MRPS Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, MRPS has a market cap of 0. Regarding current trading prices, ERFSF is priced at $67.36, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas MRPS's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to MRPS's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EPGNY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 11.9B. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, ERFSF is priced at $67.36, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 28.30, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, ERFSF's ROE is +0.07%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, ERFSF is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.